Clinical trial
The Hydrus® Microstent for Intraocular Pressure (IOP) Reduction in Mild to Moderate Open-Angle Glaucoma
NCT05198297 is registered in ClinicalTrials.gov with Alcon Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Hydrus® Microstent for Intraocular Pressure (IOP) Reduction in Mild to Moderate Open-Angle Glaucoma
- Lead sponsor
- Alcon Research
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- December 13, 2021
- Completion date
- January 31, 2024
- Enrollment
- 33 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
open angle glaucoma, pigmentary glaucoma, primary open angle glaucoma, pseudoexfoliation glaucoma